Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9952291 | 1.00 | HIF1A (0.32) | HIF1A | |
| SCHEMBL14873888 | 1.00 | HIF1A (0.32) | HIF1A | |
| SCHEMBL20169646 | 1.00 | HIF1A (0.32) | HIF1A | |
| SCHEMBL16329660 | 1.00 | HIF1A (0.32) | HIF1A | |
| SCHEMBL15773944 | 1.00 | HIF1A (0.32) | HIF1A | |
| SCHEMBL1397641 | 1.00 | HIF1A (0.32) | HIF1A | |
| SCHEMBL16329771 | 1.00 | HIF1A (0.32) | HIF1A | |
| SCHEMBL16692019 | 0.97 | — | — | |
| SCHEMBL16329560 | 0.93 | — | — | |
| SCHEMBL23130636 | 0.86 | HIF1A (0.41) | HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230372508-A1 | LINKERS COUPLING FUNCTIONAL LIGANDS TO MACROMOLECULES | OLIX US, INC. | 2023-11-23 | — | — | US | claimed |
| WO-2023225650-A1 | LINKERS COUPLING FUNCTIONAL LIGANDS TO MACROMOLECULES | OLIX US, INC. (US) | 2023-11-23 | — | — | WO | claimed |
| US-20170175129-A1 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | MODERNA THERAPEUTICS INC (US) | 2017-06-22 | — | — | US | claimed |
| US-20170136131-A1 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | Modema Therapeutics, Inc. (US) | 2017-05-18 | — | — | US | claimed |
| US-20150038435-A1 | N-TERMINALLY MODIFIED OLIGOPEPTIDES AND USES THEREOF | NOVO NORDISK A/S (DK) | 2015-02-05 | — | — | US | claimed |
| EP-2820150-A1 | N-TERMINALLY MODIFIED OLIGOPEPTIDES AND USES THEREOF | Novo Nordisk A/S (DK) | 2015-01-07 | — | — | EP | claimed |
| WO-2013128003-A1 | N-TERMINALLY MODIFIED OLIGOPEPTIDES AND USES THEREOF | NOVO NORDISK A/S (DK) | 2013-09-06 | — | — | WO | claimed |
| US-20240239852-A1 | AMYLIN RECEPTOR AGONISTS | NOVO NORDISK A/S (DK) | 2024-07-18 | — | — | US | disclosed |
| WO-2024133160-A1 | HEPATITIS B COMPOSITIONS | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-06-27 | — | — | WO | disclosed |
| EP-4387597-A1 | FREEZE-DRYING OF LIPID NANOPARTICLES (LNPS) ENCAPSULATING RNA AND FORMULATIONS THEREOF | GlaxoSmithKline Biologicals SA (BE) | 2024-06-26 | — | — | EP | disclosed |
| EP-4387596-A1 | LOW-DOSE LYOPHILIZED RNA VACCINES AND METHODS FOR PREPARING AND USING THE SAME | GlaxoSmithKline Biologicals SA (BE) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024113009-A1 | AGENTS, COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY | THE UNIVERSITY OF QUEENSLAND (AU) | 2024-06-06 | — | — | WO | disclosed |
| US-20240173400-A1 | HERPES SIMPLEX VIRUS VACCINE | MODERNATX, INC. (US) | 2024-05-30 | — | — | US | disclosed |
| US-20110293714-A1 | PHARMACEUTICAL COMPOSITIONS SUITABLE FOR ORAL ADMINISTRATION OF DERIVATIZED INSULIN PEPTIDES | NOVO NORDISK A/S (DK) | 2011-12-01 | — | — | US | disclosed |
| EP-2370059-A1 | PHARMACEUTICAL COMPOSITIONS SUITABLE FOR ORAL ADMINISTRATION OF DERIVATIZED INSULIN PEPTIDES | Novo Nordisk A/S (DK) | 2011-10-05 | — | — | EP | disclosed |
| US-20110105720-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | NOVO NORDISK A/S (DK) | 2011-05-05 | — | — | US | disclosed |
| EP-2254906-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | Novo Nordisk A/S (DK) | 2010-12-01 | — | — | EP | disclosed |
| WO-2010060667-A1 | PHARMACEUTICAL COMPOSITIONS SUITABLE FOR ORAL ADMINISTRATION OF DERIVATIZED INSULIN PEPTIDES | NOVO NORDISK A/S (DK) | 2010-06-03 | — | — | WO | disclosed |
| WO-2009115469-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | NOVO NORDISK A/S (DK) | 2009-09-24 | — | — | WO | disclosed |
| US-20090098130-A1 | GLUCAGON-LIKE PROTEIN-1 RECEPTOR (GLP-1R) AGONIST COMPOUNDS | COVX TECHNOLOGIES IRELAND LIMITED (IE) | 2009-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105720-A1 | PROTEASE STABILIZED, ACYLATED INSULIN ANALOGUES | IAPP, IDE, LIPE | HIF1A 1903/4885 |
| US-20240173400-A1 | HERPES SIMPLEX VIRUS VACCINE | STING1, RPL23, RPL17 | HIF1A 2127/4885 |
| US-20170175129-A1 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | NSUN2, RNGTT, NSUN3 | HIF1A 1292/4885 |
| US-20110293714-A1 | PHARMACEUTICAL COMPOSITIONS SUITABLE FOR ORAL ADMINISTRATION OF DERIVATIZED INSULIN PEPTIDES | IAPP, VIP, INSR | HIF1A 3570/4885 |
| US-20230372508-A1 | LINKERS COUPLING FUNCTIONAL LIGANDS TO MACROMOLECULES | DNPEP, LNPEP, FGB | HIF1A 1830/4885 |
| US-20150038435-A1 | N-TERMINALLY MODIFIED OLIGOPEPTIDES AND USES THEREOF | NGLY1, PTMS, VIP | HIF1A 3088/4885 |
| US-20090098130-A1 | GLUCAGON-LIKE PROTEIN-1 RECEPTOR (GLP-1R) AGONIST COMPOUNDS | GLP1R, GIPR, GCGR | HIF1A 1106/4885 |
| US-20170136131-A1 | ALTERNATIVE NUCLEIC ACID MOLECULES AND USES THEREOF | NSUN2, RNGTT, NSUN3 | HIF1A 1292/4885 |
| US-20240239852-A1 | AMYLIN RECEPTOR AGONISTS | GLP1R, GPR119, GIPR | HIF1A 3470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.